Status:
COMPLETED
Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
41+ years
Brief Summary
The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.
Detailed Description
MC MD
Eligibility Criteria
Inclusion
- Provision of informed consent prior to any study specific procedures
- Male or non-pregnant female aged \>40 years
- A clinical diagnosis of COPD with FEV1/ FVC \<0.70 and require combination or modified therapy
- Smoke \> 10 Pack Year
Exclusion
- Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
- Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
684 Patients enrolled
Trial Details
Trial ID
NCT01169727
Start Date
July 1 2010
End Date
March 1 2012
Last Update
May 31 2012
Active Locations (20)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
SaiMai, Bangkok, Thailand
2
Research Site
Watana, Bangkok, Thailand
3
Research Site
Maung, Changwat Chanthaburi, Thailand
4
Research Site
Maung, Changwat Chiang Rai, Thailand